Introducing FertilomeOffer Fertilome at your clinic
The future of
fertility is proactiveLearn about our vision
Celmatix is a next-generation women’s health company transforming the way women and their physicians leverage genomics and data to make more informed, proactive reproductive health decisions.
We have built the world’s largest clinical dataset on fertility treatment outcomes.
We have identified over 5,200 unique regions of the human genome that impact a person’s fertility potential.
We founded the Personalized Reproductive Medicine (PReM) Initiative, a groundbreaking research alliance of leading academic institutions and fertility treatment centers across the United States, to investigate what an individual’s genetics and other metrics say about his or her overall fertility. The PReM Initiative's goal is to revolutionize how infertility is diagnosed, treated, and eventually, prevented.